Full Approval for a HER2-targeting Therapy
The FDA has granted full approval to an antibody-drug conjugate for certain patients with breast cancer. The U.S. Food...
Progress Against Cancer
The FDA has granted full approval to an antibody-drug conjugate for certain patients with breast cancer. The U.S. Food...
The FDA approved the cellular immunotherapy axicabtagene ciloleucel for second-line treatment of patients with large B-cell lymphoma. The U.S....
The FDA has approved a radioactive compound and companion diagnostic test for patients with advanced prostate cancer. The U.S....
The FDA approved pembrolizumab for certain patients with advanced endometrial cancer with DNA repair defects The U.S. Food and...
The FDA approved nivolumab and relatlimab-rmbw (Opdualag) for some patients with advanced melanoma The U.S. Food and Drug...
The FDA approved olaparib for patients with breast cancer who have inherited BRCA mutations and have received prior neoadjuvant...
The FDA approved nivolumab in combination with chemotherapy for use before surgery in certain patients with non-small cell lung...
The FDA recently approved the second cellular immunotherapy to treat certain adult patients with multiple myeloma. The U.S. Food...
The FDA approved the targeted immunotherapy tebentafusp-tebn for certain adult patients with uveal melanoma. The U.S. Food and Drug...
The FDA approved an immune checkpoint inhibitor for patients with stage IIB or IIC melanoma following surgical removal of...